Fei Yu | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Fei Yu | Medicine and Dentistry | Best Researcher Award

Prof Fei Yu, Shanghai tenth people’s hospital, China

Prof. Fei Yu, a distinguished expert in Nuclear Medicine, holds a rich educational background with degrees from Soochow University and Fudan University. With a graduation date of June 2012 from Soochow University School of Medicine, he has dedicated himself to advancing the field of Nuclear Medicine through significant contributions and research.

Publication profile

Scopus

Education

Prof. Fei Yu graduated in June 2012 from Soochow University, where he completed his medical education. He previously attended Fudan University from September 1996 to July 2001, earning his degree from the School of Public Health and Community Medicine. Furthering his studies, Prof. Yu obtained his degree from Tongji University’s School of Medicine between March 2005 and March 2008. With a strong foundation in public health and medicine, he has made significant contributions to his field. 🌍📚🏥

Honors and Awards

Prof. Fei Yu is a distinguished researcher recognized for his significant contributions to nuclear medicine. He was awarded the Star of Hope Award by the Chinese Society of Nuclear Medicine in September 2018. His project on targeted therapy for non-small cell lung cancer, supported by the Shanghai Talent Development Fund in September 2017, highlights his innovative approach in the field. He also received the Shanghai Science and Technology Award in November 2010 for developing a 99mTc labeled somatostatin receptor imaging kit for lung cancer diagnosis. Additionally, he was honored with the Huaxia Medical Science and Technology Award and the Hospital Technology Innovation Award for his research on medical ethics and intelligent clinical pathways. 🌟🔬🏆

Research Achievements

Dr. Yang and colleagues have made significant strides in cancer therapy and cardiology. Their 2024 study in Theranostics explores how damaged mitochondrial transfer impacts the bystander effect induced by alpha-particle radiation (🎗️). Another study published in Small reveals that alpha-emitter Radium-223 triggers STING-dependent pyroptosis, enhancing antitumor immunity (💉). Additionally, they developed alpha radionuclide-chelated radioimmunotherapy promoters to advance local radiotherapy strategies, published in Biomaterials Research (📚). In cardiology, their nomogram for predicting major adverse cardiac events in patients with ischemia, featured in Frontiers in Cardiovascular Medicine, is a pivotal contribution (❤️).

Research focus

Prof. Fei Yu is a prominent researcher specializing in nuclear medicine and molecular imaging. His work encompasses the development and evaluation of advanced therapeutic approaches, particularly in the context of neuroendocrine tumors and thyroid cancer. Prof. Yu’s research focuses on innovative treatments like peptide receptor radionuclide therapy and the mechanisms of antitumor immunity, including the role of STING-dependent pyroptosis induced by alpha-emitter Radium-223. His contributions significantly enhance understanding of cancer therapies and their implications for patient prognosis. 🔬💉📈

Memberships and Leadership

Prof. Yu is an active member of several professional societies, holding key positions such as Vice Chairman of the Continuing Education Committee of Nuclear Medicine under the Chinese Nuclear Society. His involvement in these organizations reflects his dedication to the growth and education within the field, emphasizing the importance of collaboration and knowledge sharing.

Funding and Research Projects

Prof. Yu leads multiple funded projects, including the National Natural Science Foundation project on interstitial radiotherapy combined with immunotherapy for non-small cell lung cancer. His work is characterized by a strong focus on innovative therapies that integrate radiological techniques with emerging treatment modalities.

Publication top notes

Triglyceride-glucose index is associated with myocardial ischemia and poor prognosis in patients with ischemia and no obstructive coronary artery disease

The D-SPECT SH reconstruction protocol: improved quantification of small left ventricle volumes

The Effect of Radioiodine Therapy on the Prognosis of Differentiated Thyroid Cancer with Lung Metastases

Extended peptide receptor radionuclide therapy: evaluating nephrotoxicity and therapeutic effectiveness in neuroendocrine tumor patients receiving more than four treatment cycles

Alpha-Emitter Radium-223 Induces STING-Dependent Pyroptosis to Trigger Robust Antitumor Immunity

Conclusion

Prof. Fei Yu exemplifies excellence in nuclear medicine, with a career marked by substantial research contributions, leadership roles, and a commitment to advancing medical science. His innovative approaches to cancer therapy and active involvement in professional societies make him an outstanding candidate for the Best Researcher Award. Prof. Yu’s dedication to improving patient outcomes through research and education sets a high standard for future professionals in the field.

Mahmoud Ramadan | Medicine and Dentistry | Outstanding Scientist Award

Posted on by ScienceFather

Assoc Prof Dr. Mahmoud Ramadan | Medicine and Dentistry | Outstanding Scientist Award

Associate Professor at College of Medicine, University of Sharjah, United Arab Emirates

Dr. Mahmoud Ramadan is an accomplished Clinical Associate Professor with extensive expertise in cardiovascular medicine and cardiology. He holds a Doctorate in Cardiovascular Medicine from Niigata University, Japan, and has been involved in various academic and clinical roles, currently serving at both the University of Sharjah in the UAE and Mansoura University in Egypt. With multiple certifications in cardiology and significant research experience, including participation in the global INTERHEART study, Dr. Ramadan has contributed numerous publications to esteemed journals. His proficiency in statistical analysis, languages, and various medical certifications underscores his dedication to advancing cardiovascular health and education.

Publication profile

Scopus Profile 

Education Background

Dr. Mahmoud Ramadan holds an extensive educational background in the field of medicine, particularly in cardiovascular medicine. He earned his Doctorate Degree in Cardiovascular Medicine from Niigata University Graduate School of Medical and Dental Sciences in Japan, graduating in September 2008. His doctoral thesis focused on the “Impact of Percutaneous Coronary Intervention on the Levels of Interleukin-6 and C-Reactive Protein in the Coronary Circulation of Subjects with Coronary Artery Disease.” Prior to this, he completed his Master’s degree in Cardiology at Mansoura University, Egypt, where he graduated in May 2001, and his undergraduate degree, M.B.B.Ch., from the same institution in November 1995, graduating with honors. Additionally, Dr. Ramadan has pursued further professional development, obtaining various certifications, including MRCP (UK) and other specialized courses in areas such as echocardiography, abdominal ultrasonography, and atherosclerosis, thereby reinforcing his expertise in the medical field.

Research Experience

Dr. Mahmoud Ramadan has extensive research experience in cardiovascular medicine, evidenced by his impactful work as a Clinical Associate Professor and multiple roles in renowned medical institutions. He earned his PhD from Niigata University, Japan, where he explored the effects of percutaneous coronary interventions on inflammatory markers in patients with coronary artery disease. His involvement in the global “INTERHEART” study significantly contributed to understanding myocardial infarction risk factors across various populations. Dr. Ramadan has published numerous original research articles in prestigious journals, focusing on topics such as cardiac dysfunction, coronary disease, and inflammatory responses, showcasing his dedication to advancing cardiovascular science. Additionally, he has supervised both master’s and PhD students, further demonstrating his commitment to fostering future research talent in the field.

Teaching and Mentoring Experience

Dr. Mahmoud Ramadan has extensive teaching and mentoring experience in the field of cardiology and medicine. As an Associate Professor of Medicine at the University of Sharjah and the Faculty of Medicine at Mansoura University, he has contributed significantly to the education of medical students and residents. He has lectured on various topics in cardiology, sharing his expertise and fostering critical thinking among students. Additionally, Dr. Ramadan has supervised numerous master’s and PhD students, guiding them through their research projects and dissertations, which demonstrates his commitment to nurturing the next generation of medical professionals. His role as an AHA-certified instructor in Advanced Cardiovascular Life Support (ACLS) and Basic Life Support (BLS) further underscores his dedication to teaching practical skills that are essential in clinical settings. Through his mentorship and teaching, he has played a vital role in shaping the educational landscape in cardiology, emphasizing the importance of both theoretical knowledge and hands-on experience.

Work Experience

Dr. Mahmoud Ramadan has an extensive work experience in the field of cardiology and medicine, spanning over two decades. He currently serves as an Associate Professor of Medicine in the Clinical Sciences Department at the University of Sharjah, UAE, and holds a similar position at Mansoura University in Egypt. His professional journey began as a House Officer at Mansoura University Hospitals, followed by various roles including Resident Physician, Assistant Lecturer, and Lecturer in Cardiology at Mansoura University. Throughout his career, he has engaged in advanced clinical training in Japan and contributed significantly to teaching, supervision, and research in cardiovascular medicine. Additionally, Dr. Ramadan is involved in multiple professional certifications, training programs, and has contributed to several international collaborative studies, showcasing his commitment to advancing medical knowledge and practice in cardiology.

Awards, Honours & Certificates

Dr. Mahmoud Ramadan has received several prestigious awards and honors throughout his academic and professional career. Notably, he was selected as a representative of Mansoura University in the global INTERHEART study, which was published in The Lancet. He also earned the esteemed Japanese Government Monbu-Kagakusho Scholarship for his PhD in Cardiology from Niigata University. In addition, Dr. Ramadan was recognized as a Young Investigator Award Finalist at the 22nd Annual Meeting of the Japanese Section of the International Society of Heart Research. His accolades include the EJISST Award at the First Egypt-Japan International Symposium on Science and Technology and the JSPS Post-Doctoral Fellowship from the Japan Society for the Promotion of Science in 2008. His commitment to continued education is evidenced by his completion of various certifications, including in mechanical ventilation and echocardiography, as well as his membership in several distinguished medical associations.

Publication Top Notes

  • Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
    • Authors: Brauer, M., Roth, G.A., Aravkin, A.Y., Murray, C.J.L., Gakidou, E.
    • Year: 2024
    • Citations: 66
  • Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
    • Authors: Ferrari, A.J., Santomauro, D.F., Aali, A., Vos, T., Murray, C.J.L.
    • Year: 2024
    • Citations: 107
  • Targeting inflammatory signaling pathways with SGLT2 inhibitors: Insights into cardiovascular health and cardiac cell improvement
    • Authors: Alsereidi, F.R., Khashim, Z., Marzook, H., Ramadan, M.M., Saleh, M.A.
    • Year: 2024
    • Citations: 4
  • Global, regional, and national burden of upper respiratory infections and otitis media, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021
    • Authors: Sirota, S.B., Doxey, M.C., Dominguez, R.-M.V., Murray, C.J.L., Kyu, H.H.
    • Year: 2024
    • Citations: 1
  • Alchemilla vulgaris modulates isoproterenol-induced cardiotoxicity: interplay of oxidative stress, inflammation, autophagy, and apoptosis
    • Authors: Anajirih, N., Abdeen, A., Taher, E.S., Ramadan, M.M., Habotta, O.A.
    • Year: 2024
    • Citations: 0

Conclusion

Dr. Mahmoud Ramadan exemplifies the qualities of an outstanding researcher in cardiovascular medicine. His strong academic background, extensive research contributions, and clinical expertise make him a deserving candidate for the Best Researcher Award. By focusing on expanding his research scope, increasing outreach, diversifying research methodologies, and embracing innovative trends, he can further enhance his impact in the field. Awarding him this recognition would not only honor his past contributions but also encourage future advancements in cardiovascular research and patient care.

Mehmet Nur Kaya | Medicine and Dentistry | Young Scientist Award

Posted on by ScienceFather

Dr. Mehmet Nur Kaya | Medicine and Dentistry | Young Scientist Award

researcher, Gülhane Training and Research Hospital,  Rheumatology Department , Turkey

The study titled “Impact of Central Sensitization on Clinical and Functional Aspects of Psoriatic Arthritis” by Mehmet Nur Kaya et al. examines the prevalence of central sensitization (CS) in patients with psoriatic arthritis (PsA). Conducted with 103 PsA patients, the research used the Central Sensitization Inventory (CSI) to assess CS’s influence on clinical and functional markers such as disease activity, sleep quality, depression, and anxiety. The study found that 65.1% of the patients had CS, with the Psoriasis Area Severity Index (PASI), General Anxiety Disorder-7 (GAD-7), and Insomnia Severity Index (ISI) emerging as significant predictors of CS. Patients with CS demonstrated higher BMI and disease activity scores. The research highlights the importance of considering CS when assessing pain sensitivity in PsA patients. These findings underscore the potential impact of CS on clinical management, with implications for treatment strategies aimed at improving quality of life in PsA patients.

Profile:

Education

Mehmet Nur Kaya, a distinguished researcher in the field of rheumatology, earned his medical degree from a reputable institution and pursued further specialization in rheumatology. He is currently affiliated with the Rheumatology Department at Gülhane Training and Research Hospital, University of Health Sciences in Turkey. His academic journey reflects a commitment to understanding complex rheumatic diseases, particularly psoriatic arthritis (PsA). Through continuous learning and hands-on experience, Kaya has honed his skills in clinical research, diagnostics, and patient care, contributing to the advancement of medical knowledge in his field. His educational background, coupled with extensive clinical experience, has enabled him to conduct pioneering studies on central sensitization in PsA, shedding light on critical aspects of pain management and disease activity. Kaya’s dedication to education and research underscores his role as a key contributor to both academic and clinical advancements in rheumatology.

 

Professional Experiences

Dr. Mehmet Nur Kaya is a dedicated rheumatologist with extensive experience in the study and management of psoriatic arthritis (PsA) and other rheumatic conditions. As part of the Rheumatology Department at Gülhane Training and Research Hospital, University of Health Sciences, Turkey, he has made significant contributions to understanding the clinical and functional impacts of central sensitization (CS) on PsA patients. Dr. Kaya has collaborated with renowned professionals, leading numerous observational studies focused on pain sensitivity, quality of life, disease activity, and treatment outcomes in rheumatic diseases. His work with patient-centric assessments, such as the Central Sensitization Inventory (CSI), has played a critical role in shaping treatment protocols and improving patient care. Dr. Kaya is committed to advancing the field of rheumatology, combining clinical expertise with a passion for research, and continually striving to enhance the quality of life for individuals affected by chronic inflammatory diseases.

 

Research Skills

Research skills are essential for effectively gathering, analyzing, and interpreting information across various fields. These skills encompass critical thinking, allowing individuals to evaluate sources, discern credible information, and synthesize diverse viewpoints. Proficiency in quantitative and qualitative research methodologies is crucial, enabling researchers to design studies, collect data, and draw valid conclusions. Effective communication is another vital component, as researchers must articulate their findings clearly through written reports and presentations. Additionally, strong organizational skills facilitate the management of research timelines, resources, and documentation. Familiarity with digital tools and databases enhances the ability to access and utilize a wide range of resources efficiently. Lastly, ethical considerations in research, such as maintaining integrity and respecting confidentiality, are paramount to uphold the credibility of one’s work. Developing these research skills not only fosters academic and professional growth but also contributes to informed decision-making in an increasingly complex world.

Award And Recognition

The Research for Young Scientist Award recognizes outstanding contributions made by emerging researchers in the field of medical sciences, specifically focusing on the impact of central sensitization on psoriatic arthritis. This award aims to honor innovative research that enhances our understanding of chronic inflammatory diseases and their effects on patients’ quality of life. Candidates are evaluated based on their scientific rigor, originality, and potential for future contributions to the field. The award serves not only to celebrate individual achievements but also to inspire young scientists to pursue impactful research that addresses pressing health challenges. By fostering a culture of excellence and innovation, the Research for Young Scientist Award promotes the dissemination of knowledge and encourages collaboration among researchers. This recognition plays a crucial role in motivating young professionals to advance their careers and contribute significantly to the medical community.

Conclusion

The research conducted by Kaya et al. on the impact of central sensitization (CS) in patients with psoriatic arthritis (PsA) provides crucial insights into the complex interplay between pain sensitivity and disease severity. Their findings reveal that a significant proportion of PsA patients experience CS, which is associated with higher disease activity, impaired quality of life, and increased severity of psychological symptoms such as anxiety and insomnia. By utilizing the Central Sensitization Inventory (CSI), the study effectively highlights the importance of recognizing CS as a critical factor influencing the clinical and functional outcomes of PsA. The results underscore the need for healthcare professionals to consider CS in pain management strategies, aiming to improve the overall treatment approach for PsA patients. This research not only enhances the understanding of pain mechanisms in PsA but also emphasizes the necessity of comprehensive assessments to tailor interventions that address both physical and psychological aspects of the disease.

Publication Top Notes

  1. Drug-free remission is an achievable target with immunosuppressive treatment in idiopathic granulomatous mastitis
    Authors: Kaya, M.N., Tekgöz, E., Çolak, S., Çınar, M., Yılmaz, S.
    Year: 2023
    Citations: 3
    Journal: Irish Journal of Medical Science, 192(6), pp. 2815–2819
  2. Can pre-treatment inflammatory biomarker levels predict the response of tocilizumab therapy in COVID-19 patients?
    Authors: Kaya, M.N., Tecer, D., Çınar, M., Çolak, S., Yılmaz, S.
    Year: 2023
    Citations: 1
    Journal: Gulhane Medical Journal, 65(4), pp. 145–151
  3. Hospital-acquired anemia in chronic kidney disease
    Authors: Kaya, M.N., Caner, B., Toprak, Ö.
    Year: 2019
    Citations: 0
    Journal: International Journal of Scientific and Technology Research, 8(4), pp. 160–166